RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > Australia: Draft Guidance on Evidence to Support Indications for Low Risk Medicines

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe